About us

iLoF is enabling a new era of personalized medicine, by using AI and photonics to build a cloud-based library of diseases biomarkers and biological profiles, and provide screening and stratification tools in an affordable, fast, portable way. 

Selected as the winner of numerous industry awards, iLoF has been featured as one of the most disruptive companies in Europe using Photonics and Artificial Intelligence to solve the biggest healthcare challenges of our time.

Early 2016

Joana Paiva, co-founder and CTO, with Paula Sampaio, co-founder and CSO, recognizes an opportunity to apply photonics and A.I. to detect diseases during her PhD

March 2019

Joana Paiva along with co-founders, Paula Sampaio, Luis Valente and Mehak Mumtaz, begin their ‘Wild Card Journey’, to bring the technology to market

July 2019

iLoF wins the EIT Health Wild Card program

August 2019

iLoF is founded and receives its first round of funding from EIT Health

November 2019

iLoF establishes R&D operations at the Medical Faculty, University of Porto, and its commercial operations at the Oxford Foundry, Oxford University’s startup incubator

November 2019

iLoF wins the Altice Innovation Award for startups

March 2020

iLoF named one of the #50GameChangers around Oxford and the Thames Valley UK

March 2020

iLoF research published in Scientific Reports (Nature Publishing)

March 2020

iLoF co-founders named in Forbes’ 30 Under 30 List for Science and Healthcare

March 2020

iLoF is chosen as  one of the 10 DeepTech businesses at the Mayor of London’s Techinvest

April 2020

iLof enters Google for Startups UK accelerator program

July 2020

ILoF wins Microsoft Female Founders Competition for Deeptech startups and receives investment from M12 and Mayfield Fund

(+351) 220 426 664 / (+44) 01865 679064


Oxford Foundry – University of Oxford
3-5 Hythe Bridge St
Oxford – United Kingdom

Medical Research Center - Faculty of Medicine of University of Porto - Alameda Prof. Hernâni Monteiro Porto - Portugal


Privacy Policy